Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin Supplementation as Adjuvant Therapy for Prevention of Bronchopulmonary Dysplasia in Neonates
TCTR20191211004Phase 1Completed
- Sponsor
- Tanta University Hospitals
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of melatonin in bronchopulmonary dysplasia (BPD), sponsored by Tanta University Hospitals. Started Jul 2016; status: completed.
02
Drugs
melatonin
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on TCTR20191211004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20191211004.